Andrew John Oakley serves as Executive at Onconetix, Inc., where they oversee executive responsibilities. Since joining the company, Andrew John Oakley has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 15, 2025 involved receiving (via award) 618 shares valued at $0.
Andrew John Oakley currently holds 638 shares of Onconetix, Inc. (ONCO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew John Oakley has been a net neutral trader of ONCO stock. They have purchased $0 and sold $0 worth of shares.
Andrew John Oakley's most recent insider trade was on Aug 15, 2025, when they sold 618 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |